Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-12 Soffer Donald M Director Purchase +100,000 $10.00 $1.0M 153,514
2021-02-12 Hare Joshua Chief Scientific Officer Purchase +102,000 $10.00 $1.0M 7,997,428
2021-02-12 Hare Joshua Chief Scientific Officer Purchase +1,000 $8.23 $8K 7,998,428
2021-02-11 Borger Erin Director Returned to the company −5,000 0
2021-02-11 Ross Cathy Director Grant or award +5,000 5,000
2021-02-11 Borger Erin Director Grant or award +5,000 5,000
2021-02-11 LOSORDO DOUGLAS W Director Grant or award +5,000 5,000

Page 15 of 15 · 287 trades